BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38299075)

  • 1. HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
    Fokom Domgue J; Dille I; Kapambwe S; Yu R; Gnangnon F; Chinula L; Murenzi G; Mbatani N; Pande M; Sidibe F; Kamgno J; Traore B; Fazazi HE; Diop M; Tebeu PM; Diomande MI; Lecuru F; Adewole I; Plante M; Basu P; Dangou JM; Shete S
    Front Public Health; 2024; 12():1343064. PubMed ID: 38299075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
    Topazian HM; Kundu D; Peebles K; Ramos S; Morgan K; Kim CJ; Richter KL; Brewer NT; Peris M; Smith JS
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):575-582.e2. PubMed ID: 30017958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
    Berkowitz Z; Malone M; Rodriguez J; Saraiya M
    Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare providers' practice protocols, strategies, and needed tools to address parental HPV vaccine hesitancy: An exploratory study.
    Cunningham-Erves J; Hull PC; Wilkins CH; Edwards KM; Davis M; Jones J; Graham J; Adekunle A; Dempsey AF
    Hum Vaccin Immunother; 2022 Nov; 18(6):2136862. PubMed ID: 36375029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the factors contributing to low vaccination uptake for nationally recommended routine childhood and adolescent vaccines in Kenya.
    Essoh TA; Adeyanju GC; Adamu AA; Tall H; Aplogan A; Tabu C
    BMC Public Health; 2023 May; 23(1):912. PubMed ID: 37208649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey.
    Chen S; Mei C; Huang W; Liu P; Wang H; Lin W; Yuan S; Wang Y
    BMC Womens Health; 2022 May; 22(1):169. PubMed ID: 35568870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.
    Albayat SS; Mundodan JM; Elmardi K; Hasnain S; Khogali H; Baaboura R; Al-Romaihi HE; AlKubaisi NJ; Bougmiza MI
    Womens Health (Lond); 2024; 20():17455057241227360. PubMed ID: 38282514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations.
    Bruno DM; Wilson TE; Gany F; Aragones A
    Vaccine; 2014 Jul; 32(33):4149-54. PubMed ID: 24886959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV vaccine hesitancy: findings from a statewide survey of health care providers.
    McRee AL; Gilkey MB; Dempsey AF
    J Pediatr Health Care; 2014; 28(6):541-9. PubMed ID: 25017939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countries.
    Topazian HM; Dizon AM; Di Bona VL; Levitz L; Ramos S; Morgan K; Kim CJ; Richter K; De Sanjose S; Smith JS
    Hum Vaccin Immunother; 2019; 15(7-8):1672-1677. PubMed ID: 30625017
    [No Abstract]   [Full Text] [Related]  

  • 11. Feasibility of using an app-based coaching intervention to improve provider communication about HPV vaccination.
    Grabert BK; McRee AL; Henrikson NB; Heisler-MacKinnon J; Blasi PR; Norris CM; Nguyen MB; Dunn J; McKeithen MC; Gilkey MB
    Transl Behav Med; 2023 Aug; 13(8):581-588. PubMed ID: 36999806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.
    Roland KB; Benard VB; Greek A; Hawkins NA; Saraiya M
    Vaccine; 2014 Sep; 32(42):5432-5. PubMed ID: 25131744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation.
    Malo TL; Hall ME; Brewer NT; Lathren CR; Gilkey MB
    Implement Sci; 2018 Apr; 13(1):57. PubMed ID: 29673374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
    Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study.
    Abi Jaoude J; Khair D; Dagher H; Saad H; Cherfan P; Kaafarani MA; Jamaluddine Z; Ghattas H
    Vaccine; 2018 Nov; 36(49):7562-7567. PubMed ID: 30420044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining HPV Vaccination Practices and Differences Among Providers in Virginia.
    Alcalá HE; Maxwell GL; Lindsay B; Keim-Malpass J; Mitchell EM; Balkrishnan R
    J Cancer Educ; 2020 Feb; 35(1):159-164. PubMed ID: 30520008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are health care providers making the most of patient encounters to promote HPV vaccination among cigarette smokers?
    Wigfall LT; Sherman LD; Garney WR; Patterson MS; Montiel Ishino FA; Vadaparampil ST
    Patient Educ Couns; 2020 Jan; 103(1):180-188. PubMed ID: 31383561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare providers' perspectives on the acceptability and uptake of HPV vaccines in Zimbabwe.
    Crann SE; Barata PC; Mitchell R; Mawhinney L; Thistle P; Chirenje ZM; Stewart DE
    J Psychosom Obstet Gynaecol; 2016 Dec; 37(4):147-155. PubMed ID: 27400371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
    Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
    Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.